Page last updated: 2024-11-06

ximenynic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ximenynic acid: isolated from Santalum accuminatum; structure given in first source; RN given refers to (E)-isomer (santalbic acid) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
SantalumgenusA plant genus of the family SANTALACEAE which is the source of sandalwood oil.[MeSH]SantalaceaeA plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasites that form connections (haustoria) to their hosts to obtain water and nutrients. The one-seeded fruit may be surrounded by a brightly colored nut-like structure.[MeSH]

Cross-References

ID SourceID
PubMed CID5312688
CHEMBL ID1967321
CHEBI ID165495
SCHEMBL ID40759
MeSH IDM0152178

Synonyms (31)

Synonym
santalbic acid
NSC252625 ,
trans-11-octadecen-9-ynoic acid
557-58-4
ximeninic acid
ximenynic acid
nsc-252625
11-octadecen-9-ynoic acid, (e)-
LMFA01030560
agonandoic acid
11e-octadecen-9-ynoic acid
(e)-octadec-11-en-9-ynoic acid
CHEBI:165495
A831391
einecs 209-179-1
unii-ia0z48p13w
ia0z48p13w ,
nsc 252625
hydror il
11-octadecen-9-ynoic acid, (11e)-
xymenynic acid
xymenynic acid [inci]
xymenynic acid [who-dd]
SCHEMBL40759
xymenic acid
CHEMBL1967321
ximeninic acid, aldrichcpr
11(e)-octadecen-9-ynoic acid
Q27280625
DTXSID501317249
(11e)-octadec-11-en-9-ynoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
long-chain fatty acidA fatty acid with a chain length ranging from C13 to C22.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's3 (33.33)18.2507
2000's1 (11.11)29.6817
2010's2 (22.22)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]